Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas. Read more about Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas.
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Read more about Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Outcomes Committee. Read more about Radiation Therapy Oncology Group. Research Plan 2002-2006. Outcomes Committee.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. Read more about Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee.
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Read more about Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Read more about Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid.
Intraoperative radiation therapy for high-risk pediatric neuroblastoma. Read more about Intraoperative radiation therapy for high-risk pediatric neuroblastoma.
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Read more about Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Read more about Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Read more about Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
